Sonio

Although medical professionals are highly trained, interpretive diagnostic tools such as ultrasound scans present particular challenges, and tools to help better the process are so-far scarce. In particular, finding congenital malformations – or birth defects – in foetuses has proven difficult, as there are numerous conditions with an array of markers. Sonio’s diagnostics combine medical history and genetic data to identify prenatal risks for each patient, highlighting what the physician should be looking for. This is further combined with ultrasound semiology – which searches for markers in the scan – to ensure the practitioner does not overlook anything.

Sonio is backed by leading ultrasound manufacturers, and by major private clinics. The company has raised funds to fuel its future, including adding image recognition to the platform, expanding in Europe, preparing to cross into the US, developing its tech, and investing in marketing and sales.